drugset / Trial / NCT00289874
Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a 3-week study to evaluate FEV1 following treatment with drugs in persistent asthma which is also active during allergy seasons in pediatric patients with seasonal aeroallergen sensitivity.
Timeline
- Start
- 2006-03
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 5 mg | Oral |